Report: Part D bills would pinch providers
Dementia cure predicted by 2020, British scientist asserts
The report, conducted by PricewaterhouseCoopers, shows the detrimental effects of a proposed 14-day reimbursement cycle. Up-front costs to prescription drug plans in the form of computers and software, plus the higher annual costs incurred by processing claims faster would be substantial, according to the report.
The House and Senate last year introduced legislation (H.R. 1474 and S. 1954) that would mandate payment time frames and standards in the Part D program. Prescription drug plans currently reimburse pharmacists according to an agreed upon contract, usually 30 days from the time of a claim. The legislation would cost Medicare and its beneficiaries up to $7.8 billion over the next decade, the report found.
To view the March 26 report in its entirety, go to: http://www.pcmanet.org/newsroom/2008/Documents/PwC%20Prompt%20Pay%20Report%20March%202008.pdf.